84T-13777-05682
3 vaccinations
9 coded responses
27 check-ins
9 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 750 / TX
- Registered
- 2021-02-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2021-02-21
Registered in v-safe
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-23
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Lymph node swelling under the arm I received the 2nd COVID shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-05-22
- 2021-08-21
-
2021-08-25
Dose 3 — Pfizer-BioNTech
- 2021-08-25
-
2021-08-26
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessFree text: Lymph node in underarm is swollen and hurts (same arm I received shot)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-27
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-29
Survey response — days 1–6 daily, dose 3MedDRA: Dyspnoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Still having issues breathing but am okMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-30
Survey response — days 1–6 daily, dose 3MedDRA: Respiratory disorder — Feeling: FairFree text: Still having some issues breathing but it has gotten betterMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-31
Survey response — days 1–6 daily, dose 3MedDRA: Respiratory disorder — Feeling: FairFree text: Still having breathing problems but they are better than yesterdayMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-01
Survey response — day 7, dose 3MedDRA: Dyspnoea — Feeling: FairFree text: Still having problems breathingMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-08
- 2021-09-15
- 2021-09-22
-
2021-09-29
Survey response — day 35, dose 3MedDRA: Hepatic enzyme increased, Laboratory test abnormal, Pre-existing disease — Feeling: GoodFree text: Had lab work done for my leukemia and they found a severe elevated liver testMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Survey response — day 42, dose 3MedDRA: Pneumonia, Staphylococcal infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Pneumonia and a staph infectionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2021-10-12
- 2021-11-24
-
2022-02-23
Survey response — 6 months, dose 3MedDRA: Chemotherapy, Pleural effusion, Pulmonary oedema — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Chest and lungs have filled with fluid due to chemo side effectMedDRA releases: 2024-11 · check-in free text available
-
2022-02-23
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-24
- 2022-03-01
- 2022-08-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech | |
| 3 | 2021-08-25 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Lymph node swelling under the arm I received the 2nd COVID shot
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Lymph node in underarm is swollen and hurts (same arm I received shot)
Systemic reaction (other): Still having issues breathing but am ok
Systemic reaction (other): Still having some issues breathing but it has gotten better
Systemic reaction (other): Still having breathing problems but they are better than yesterday
Release 9 — day 7, dose 3
Systemic reaction (other): Still having problems breathing
Release 9 — day 35, dose 3
Symptoms: Had lab work done for my leukemia and they found a severe elevated liver test
Release 10 — day 42, dose 3
Symptoms: Pneumonia and a staph infection
Release 11 — 6 months, dose 3
Symptoms: Chest and lungs have filled with fluid due to chemo side effect
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chemotherapy | · | · | ✓ |
| SD | Hepatic enzyme increased | · | · | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | Pleural effusion | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pulmonary oedema | · | · | ✓ |
| SD | Staphylococcal infection | · | · | ✓ |
| SRO | Dyspnoea | ✓ | · | ✓ |
| SRO | Lymph node pain | ✓ | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Respiratory disorder | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release